OKYO Pharma (OKYO) Retained Earnings (2021 - 2025)

OKYO Pharma (OKYO) has 5 years of Retained Earnings data on file, last reported at -$145.6 million in Q3 2025.

• Retained Earnings for Q3 2025 came in at -$145.6 million, changed 0.28% year-over-year; the trailing twelve-month figure through Sep 2025 was -$145.6 million (changed 0.28% YoY), and the FY2025 annual result was -$143.0 million, changed 0.35% from the prior year.
• Retained Earnings slipped to -$145.6 million in Q3 2025 per OKYO's latest filing, from -$143.0 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$106.0 million in Q1 2021 and troughed at -$145.6 million in Q3 2025.
• A 5-year average of -$131.9 million and a median of -$138.5 million in 2023 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings decreased 13.39% in 2024, then slipped 0.28% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$106.0 million in 2021, then dropped by 6.06% to -$112.4 million in 2022, then decreased by 19.65% to -$134.5 million in 2023, then slipped by 7.95% to -$145.2 million in 2024, then slipped by 0.28% to -$145.6 million in 2025.
• Business Quant data shows OKYO's Retained Earnings at -$145.6 million in Q3 2025, -$143.0 million in Q1 2025, and -$145.2 million in Q3 2024.